ArticleActa dermato-venereologica2025

Dupilumab Achieves Early Disease Control in Bullous Pemphigoid: A Case Series with TARC-based Biomarker Evaluation.

Saori Takamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.